(Q34170260)

31 July 2017

1 reference

title

Liver transplantation. Selection, listing criteria, and preoperative management (English)

1 reference

31 July 2017

main subject

liver transplantation

1 reference

Saab S

1

1 reference

31 July 2017

Han SH

series ordinal

2

1 reference

31 July 2017

Martin P

series ordinal

3

1 reference

31 July 2017

publication date

1 August 2000

1 reference

31 July 2017

published in

Clinics in liver disease

1 reference

31 July 2017

volume

4

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

513-532

1 reference

Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

The pruritus of cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Open-label trial of oral nalmefene therapy for the pruritus of cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

A controlled trial of naloxone infusions for the pruritus of chronic cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Branched chains revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Esophagitis associated with the use of alendronate

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Hepatic decompensation in patients with cirrhosis during infection with influenza A.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Transjugular intrahepatic portosystemic shunts: accuracy of Doppler US in determination of patency and detection of stenoses

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Newer approaches to therapy of hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Long term results (greater than 5 years) in patients with peritoneovenous shunting for intractable ascites: liver function and cancer mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

LeVeen vs Denver peritoneovenous shunts for intractable ascites of cirrhosis. A randomized, prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Paracentesis with Intravenous Infusion of Albumin as Compared with Peritoneovenous Shunting in Cirrhosis with Refractory Ascites

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Complications after peritoneovenous shunting for ascites

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomised, placebo-controlled multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Frequency and significance of intrapulmonary right-to-left shunting in end-stage hepatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Subcutaneous seeding of hepatocellular carcinoma following fine-needle aspiration biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

The pruritus of cholestasis: from bile acids to opiate agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Bone changes in alcoholic liver cirrhosis. A histomorphometrical analysis of 52 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Transvenous intrahepatic portosystemic shunts

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Doppler sonography findings associated with transjugular intrahepatic portosystemic shunt malfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Transjugular intrahepatic portosystemic shunts: current status

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Infections due to non-O1 Vibrio cholerae in southern Taiwan: predominance in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Hepatopulmonary syndrome: an evolving perspective in the era of liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

The hepatopulmonary syndrome. Effect of liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

The hepatopulmonary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Peritoneovenous shunt in the management of the hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: Relevance of ascitic fluid protein concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Diagnosis and staging of hepatocellular carcinoma: comparison of CT and sonography in 36 liver transplantation patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Hepatic tumors: differentiation by transverse relaxation time (T2) of magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Treatment of pruritus of primary biliary cirrhosis with rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Subclinical hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Functional renal failure with cirrhosis. The effect of plasma expansion therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Indications for and timing of liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Albumin infusion for spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Management of adult patients with ascites caused by cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Selective intestinal decontamination prevents spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Stenosis of transjugular intrahepatic portosystemic shunts: presentation and management

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Failure of rifampin to relieve pruritus in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Prostaglandins: Modulators of Renal Function and Pressor Resistance in Chronic Liver Disease*

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

Efficacy of a surveillance program for early detection of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970124-0

7 January 2021

10.1016/S1089-3261(05)70124-0

Identifiers

DOI

1 reference

release_o6cpa662yrct5ccicb5nwlfuom

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/o6cpa662yrct5ccicb5nwlfuom

24 November 2022

mapped directly with Wikidata item

1 reference